These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28394513)

  • 1. The Antidepressant Effect of Repeat Dose Intravenous Ketamine Is Delayed by Concurrent Benzodiazepine Use.
    Albott CS; Shiroma PR; Cullen KR; Johns B; Thuras P; Wels J; Lim KO
    J Clin Psychiatry; 2017 Mar; 78(3):e308-e309. PubMed ID: 28394513
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketamine and Monoamine Oxidase Inhibitor Combination: Utility, Safety, Efficacy?
    Bottemanne H; Bonnard E; Claret A; Petit AC; Gaillard R; Fossati P
    J Clin Psychopharmacol; 2020; 40(6):636-638. PubMed ID: 33009225
    [No Abstract]   [Full Text] [Related]  

  • 3. Ineffectiveness of Repeated Intravenous Ketamine Infusions in Treatment-Resistant Depression After a Post-Ketamine Relapse: Time for a Rethink?
    López-Díaz Á; Fernández-González JL
    J Clin Psychopharmacol; 2018 Oct; 38(5):534-536. PubMed ID: 30106877
    [No Abstract]   [Full Text] [Related]  

  • 4. Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression.
    Ford N; Ludbrook G; Galletly C
    Aust N Z J Psychiatry; 2015 Dec; 49(12):1227. PubMed ID: 26058787
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
    De Gioannis A; De Leo D
    Aust N Z J Psychiatry; 2014 Jul; 48(7):686. PubMed ID: 24452289
    [No Abstract]   [Full Text] [Related]  

  • 6. Repeated S-ketamine infusions in therapy resistant depression: a case series.
    Segmiller F; Rüther T; Linhardt A; Padberg F; Berger M; Pogarell O; Möller HJ; Kohler C; Schüle C
    J Clin Pharmacol; 2013 Sep; 53(9):996-8. PubMed ID: 23893490
    [No Abstract]   [Full Text] [Related]  

  • 7. The Concurrent Treatment With Intravenous Ketamine and an Irreversible Monoamine Oxidase Inhibitor for Treatment-Resistant Depression Without Hypertensive Crises.
    Wang JCC; Swainson J
    J Clin Psychopharmacol; 2020; 40(5):515-517. PubMed ID: 32740556
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic Syndrome Rather Than Body Mass Index Is Associated With Treatment Response to Ketamine Infusions.
    Dale RM; Bryant KA; Thompson NR
    J Clin Psychopharmacol; 2020; 40(1):75-79. PubMed ID: 31834094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine helps a third of patients with treatment resistant depression, finds small UK study.
    Torjesen I
    BMJ; 2014 Apr; 348():g2576. PubMed ID: 24699320
    [No Abstract]   [Full Text] [Related]  

  • 10. Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression.
    Shiroma PR; Johns B; Kuskowski M; Wels J; Thuras P; Albott CS; Lim KO
    J Affect Disord; 2014 Feb; 155():123-9. PubMed ID: 24268616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial pre-ECT ketamine infusion in a patient with treatment-resistant depression.
    Sultan R; Riva-Posse P; Garlow SJ; Schwartz AC
    Psychosomatics; 2014; 55(4):396-399. PubMed ID: 24735865
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous ketamine for treatment-resistant major depressive disorder.
    Covvey JR; Crawford AN; Lowe DK
    Ann Pharmacother; 2012 Jan; 46(1):117-23. PubMed ID: 22190250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.
    Cusin C; Ionescu DF; Pavone KJ; Akeju O; Cassano P; Taylor N; Eikermann M; Durham K; Swee MB; Chang T; Dording C; Soskin D; Kelley J; Mischoulon D; Brown EN; Fava M
    Aust N Z J Psychiatry; 2017 Jan; 51(1):55-64. PubMed ID: 26893373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic.
    Diamond PR; Farmery AD; Atkinson S; Haldar J; Williams N; Cowen PJ; Geddes JR; McShane R
    J Psychopharmacol; 2014 Jun; 28(6):536-44. PubMed ID: 24699062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence.
    Lipsitz O; McIntyre RS; Rodrigues NB; Kaster TS; Cha DS; Brietzke E; Gill H; Nasri F; Lin K; Subramaniapillai M; Kratiuk K; Teopiz K; Lui LMW; Lee Y; Ho R; Shekotikhina M; Mansur RB; Rosenblat JD
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110126. PubMed ID: 33031861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.
    Murrough JW; Perez AM; Pillemer S; Stern J; Parides MK; aan het Rot M; Collins KA; Mathew SJ; Charney DS; Iosifescu DV
    Biol Psychiatry; 2013 Aug; 74(4):250-6. PubMed ID: 22840761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital.
    Wilkinson ST; Katz RB; Toprak M; Webler R; Ostroff RB; Sanacora G
    J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 30063304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development.
    Frye MA; Blier P; Tye SJ
    J Clin Psychopharmacol; 2015 Jun; 35(3):334-6. PubMed ID: 25928701
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous ketamine infusion for a patient with treatment-resistant major depression: a 10-month follow-up.
    Kwon JH; Sim WS; Hong JP; Song IS; Lee JY
    J Clin Pharm Ther; 2018 Aug; 43(4):581-583. PubMed ID: 29372569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression.
    Szymkowicz SM; Finnegan N; Dale RM
    J Affect Disord; 2013 May; 147(1-3):416-20. PubMed ID: 23182590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.